References
- Singh N, Djamali A, Lorentzen D, et al. Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes. Transplantation 2010;90:1079–84.
- Stegall M, Chedid M, Cornell, L. The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol 2012;8:670–8.
- Solez K, Colvin R, Racusen L, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008;8:753–60.
- Nickeleit V, Mengel M, Colvin, R. Renal transplant pathology. In: Jennette J, Olsen J, Silva F, D’Agati V, eds. Heptinstall’s Pathology of the Kidney, 7th ed. Philadelphia, PA: Wolters Kluwer, 2014, p. 1381.
- Ivanyi B. A primer on recurrent and de novo glomerulonephritis in renal allografts. Nat Clin Pract Nephrol 2008;4:446–57.
- Giannico G, Arnold S, Langone A, et al. Non-IgA mesangial immune complex glomerulonephritis in kidney transplants. Hum Pathol 2015;46(10):1521–8. doi: 10.1016.
- Nickeleit V, Mengel M, Colvin R. Renal transplant pathology. In: Jennette J, Olsen J, Silva F, D’Agati V, eds. Heptinstall’s Pathology of the Kidney, 7th ed. Philadelphia, PA: Wolters Kluwer, 2014, p. 1436.
- Bomback A. Eculizumab in the treatment of membranoproliferative glomerulonephritis. Nephron Clin Pract 2014;128:270–6.
- Kikic Z, Kozakowski N, Regele H, et al. Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allografts. Transpl Int 2014;27:312–21.
- Bromfield M, McQuillan R, John R, et al. The significance of tubuloreticular inclusions as a marker of systemic stimulation by interferons in a case of focal and segmental glomerulosclerosis associated with cytomegalovirus (CMV) infection. Clin Kidney J 2014;7:174–8.
- Lee C-J, Suh K-S, Kim K-H, et al. The clinicopathologic significance of endothelial tubuloreticular inclusions in glomerular diseases. Ultrastruct Pathol 2013;37(6): 386–94.
- Herlitz L, Bomback S, Markowitz G, et al. Pathology after eculizumab in dense deposit disease and C3 GN. J Am Soc Nephrol 2012;23:1–9.
- Liptak P, Ivanyi B. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2006;2:398–404.